Question 1

Does Goldman Sachs Group own MDGL stock?

Accepted Answer

Yes. As of its Q2 2026 13F, Goldman Sachs Group holds 246,280 shares of MDGL (Madrigal Pharmaceuticals), worth $132.2M.

Question 2

How many shares of MDGL does Goldman Sachs Group own?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group holds 246,280 shares of MDGL (Madrigal Pharmaceuticals).

Question 3

What is Goldman Sachs Group's MDGL position worth?

Accepted Answer

As of its Q2 2026 13F, Goldman Sachs Group's MDGL position is worth $132.2M.

Question 4

Is Goldman Sachs Group buying or selling MDGL?

Accepted Answer

In Q2 2026, Goldman Sachs Group reduced its MDGL position by 31,091 shares (-11.2%).

Question 5

When did Goldman Sachs Group first buy MDGL?

Accepted Answer

Goldman Sachs Group already held MDGL in its Q2 2022 13F, the earliest on record, and has listed it in 17 quarterly 13F filings.

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Decreased	246,280	-11.2%	$132.2M	0.0%	$536.95	0
2026-Q1	Decreased	277,371	-9.3%	$145.2M	0.0%	$523.47	0
2025-Q4	Decreased	305,847	-20.8%	$178.1M	0.0%	$582.34	0
2025-Q3	Increased	386,100	+103.4%	$177.1M	0.0%	$458.66	49
2025-Q2	Increased	189,840	+0.1%	$57.5M	0.0%	$302.64	29
2025-Q1	Decreased	189,639	-18.1%	$62.8M	0.0%	$331.23	0
2024-Q4	Decreased	231,450	-3.5%	$71.4M	0.0%	$308.57	0
2024-Q3	Increased	239,780	+39.9%	$50.9M	0.0%	$212.22	39